RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Chambers to Vascular Endothelial Growth Factor A

Back to Details
This is a "connection" page, showing publications James Chambers has written about Vascular Endothelial Growth Factor A.
James Chambers
Connection Strength
0.055
Vascular Endothelial Growth Factor A
  1. Yokota S, Fujii W, Motegi T, Komori M, Nishi R, Chambers JK, Uchida K, Yonezawa T, Momoi Y, Maeda S. Sorafenib inhibits myeloid-derived suppressor cell infiltration in canine transitional cell carcinoma. Vet Immunol Immunopathol. 2025 Dec; 290:111019.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support